Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eyelid Neoplasms | 2 | 2020 | 43 | 0.990 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2020 | 20 | 0.710 |
Why?
|
| Orbital Neoplasms | 4 | 2023 | 65 | 0.450 |
Why?
|
| Orbital Diseases | 4 | 2021 | 92 | 0.380 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2008 | 34 | 0.300 |
Why?
|
| Hamartoma | 2 | 2007 | 52 | 0.280 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2007 | 20 | 0.280 |
Why?
|
| Cartilage | 1 | 2007 | 49 | 0.280 |
Why?
|
| Chondrocytes | 1 | 2007 | 50 | 0.270 |
Why?
|
| Mesoderm | 1 | 2007 | 109 | 0.270 |
Why?
|
| Calcinosis | 1 | 2007 | 177 | 0.250 |
Why?
|
| Optic Nerve Diseases | 2 | 2023 | 89 | 0.250 |
Why?
|
| Orbital Implants | 2 | 2021 | 18 | 0.230 |
Why?
|
| Cornea | 5 | 2018 | 654 | 0.230 |
Why?
|
| Fasciitis | 1 | 2024 | 20 | 0.230 |
Why?
|
| Nasolacrimal Duct | 1 | 2024 | 22 | 0.220 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2024 | 22 | 0.220 |
Why?
|
| Canaliculitis | 1 | 2023 | 3 | 0.220 |
Why?
|
| Eye Infections, Fungal | 3 | 2018 | 77 | 0.220 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2023 | 61 | 0.210 |
Why?
|
| Candidiasis | 3 | 2018 | 128 | 0.210 |
Why?
|
| Cysts | 1 | 2023 | 101 | 0.200 |
Why?
|
| Dermoid Cyst | 1 | 2023 | 34 | 0.200 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2023 | 163 | 0.200 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2018 | 87 | 0.180 |
Why?
|
| Orbital Fractures | 1 | 2021 | 38 | 0.180 |
Why?
|
| Keratitis | 2 | 2018 | 116 | 0.170 |
Why?
|
| Choroid Neoplasms | 1 | 1999 | 25 | 0.160 |
Why?
|
| Nevus, Pigmented | 1 | 1999 | 31 | 0.160 |
Why?
|
| Systemic Vasculitis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Hemangioblastoma | 1 | 2018 | 12 | 0.150 |
Why?
|
| Candida parapsilosis | 1 | 2018 | 2 | 0.150 |
Why?
|
| Exophthalmos | 1 | 2018 | 37 | 0.140 |
Why?
|
| Stomach Neoplasms | 1 | 2023 | 544 | 0.140 |
Why?
|
| Melanoma | 2 | 2009 | 835 | 0.140 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 53 | 0.140 |
Why?
|
| Diagnosis, Differential | 4 | 2023 | 1879 | 0.140 |
Why?
|
| Neoplasms, Second Primary | 1 | 1999 | 152 | 0.140 |
Why?
|
| Orbit | 1 | 2018 | 102 | 0.140 |
Why?
|
| Retinal Neoplasms | 1 | 2018 | 100 | 0.140 |
Why?
|
| Sclera | 2 | 2009 | 58 | 0.130 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2018 | 260 | 0.120 |
Why?
|
| Conjunctival Neoplasms | 1 | 2013 | 22 | 0.110 |
Why?
|
| Eye Neoplasms | 1 | 2013 | 49 | 0.110 |
Why?
|
| Humans | 26 | 2024 | 124149 | 0.110 |
Why?
|
| Laryngeal Neoplasms | 1 | 2013 | 80 | 0.100 |
Why?
|
| Retinal Detachment | 1 | 2013 | 83 | 0.100 |
Why?
|
| Uveal Neoplasms | 2 | 2013 | 54 | 0.100 |
Why?
|
| Orbital Myositis | 1 | 2012 | 4 | 0.100 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 10 | 0.100 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 27 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 2089 | 0.100 |
Why?
|
| Female | 21 | 2024 | 66276 | 0.090 |
Why?
|
| Ileal Neoplasms | 1 | 1990 | 6 | 0.090 |
Why?
|
| Eye Enucleation | 4 | 2013 | 54 | 0.080 |
Why?
|
| Carcinoid Tumor | 1 | 1990 | 25 | 0.080 |
Why?
|
| Eyelid Diseases | 2 | 2023 | 73 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 814 | 0.080 |
Why?
|
| Visual Acuity | 5 | 2018 | 824 | 0.080 |
Why?
|
| Endothelium, Corneal | 2 | 1989 | 45 | 0.080 |
Why?
|
| Aged | 8 | 2023 | 19532 | 0.080 |
Why?
|
| Candida albicans | 2 | 2000 | 75 | 0.080 |
Why?
|
| Gold Radioisotopes | 1 | 2009 | 3 | 0.080 |
Why?
|
| Descemet Membrane | 1 | 1989 | 16 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 662 | 0.080 |
Why?
|
| Brachytherapy | 1 | 2009 | 75 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 3549 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2009 | 141 | 0.070 |
Why?
|
| Strabismus | 1 | 2007 | 48 | 0.070 |
Why?
|
| Blepharoptosis | 1 | 2007 | 67 | 0.070 |
Why?
|
| Triamcinolone | 2 | 2012 | 13 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 417 | 0.060 |
Why?
|
| Glucocorticoids | 3 | 2012 | 380 | 0.060 |
Why?
|
| Male | 15 | 2024 | 60994 | 0.060 |
Why?
|
| Eyelids | 2 | 2023 | 119 | 0.060 |
Why?
|
| Erdheim-Chester Disease | 1 | 2004 | 25 | 0.060 |
Why?
|
| Fusobacterium Infections | 1 | 2004 | 14 | 0.060 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2004 | 8 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2004 | 22 | 0.060 |
Why?
|
| Dacryocystorhinostomy | 1 | 2024 | 27 | 0.060 |
Why?
|
| Fusobacterium nucleatum | 1 | 2004 | 24 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2008 | 668 | 0.060 |
Why?
|
| Blindness | 1 | 2004 | 72 | 0.050 |
Why?
|
| Dyspnea | 1 | 2004 | 152 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2004 | 116 | 0.050 |
Why?
|
| Durapatite | 1 | 2003 | 17 | 0.050 |
Why?
|
| Eye Infections, Bacterial | 1 | 2004 | 92 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2003 | 42 | 0.050 |
Why?
|
| Middle Aged | 11 | 2018 | 26587 | 0.050 |
Why?
|
| Twins, Monozygotic | 1 | 2023 | 117 | 0.050 |
Why?
|
| Pericardium | 1 | 2003 | 81 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 93 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 297 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 1989 | 853 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1475 | 0.040 |
Why?
|
| Fundus Oculi | 2 | 2018 | 64 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 151 | 0.040 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 56 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 1309 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2023 | 1179 | 0.040 |
Why?
|
| Fluorescein Angiography | 2 | 2018 | 142 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 1999 | 7 | 0.040 |
Why?
|
| Contact Lenses | 1 | 1999 | 45 | 0.040 |
Why?
|
| Melanocytes | 1 | 1999 | 47 | 0.040 |
Why?
|
| Keloid | 1 | 1998 | 10 | 0.040 |
Why?
|
| Mycophenolic Acid | 1 | 2018 | 51 | 0.040 |
Why?
|
| Pyridones | 1 | 1998 | 111 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2021 | 467 | 0.040 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 647 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 2018 | 129 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 307 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 6464 | 0.030 |
Why?
|
| Conjunctival Diseases | 1 | 1996 | 33 | 0.030 |
Why?
|
| Vasculitis | 1 | 1996 | 49 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 2018 | 288 | 0.030 |
Why?
|
| Infant | 3 | 2007 | 12466 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1107 | 0.030 |
Why?
|
| Skin Diseases | 1 | 1996 | 129 | 0.030 |
Why?
|
| Scleral Diseases | 1 | 2013 | 1 | 0.030 |
Why?
|
| Muscle Neoplasms | 1 | 2013 | 20 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 523 | 0.030 |
Why?
|
| Injections, Intraocular | 1 | 2012 | 10 | 0.030 |
Why?
|
| Eye Pain | 1 | 2012 | 11 | 0.030 |
Why?
|
| Diplopia | 1 | 2012 | 40 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2012 | 64 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 611 | 0.020 |
Why?
|
| Adult | 7 | 2009 | 29339 | 0.020 |
Why?
|
| Chromogranin A | 1 | 1990 | 5 | 0.020 |
Why?
|
| Synaptophysin | 1 | 1990 | 17 | 0.020 |
Why?
|
| Chromogranins | 1 | 1990 | 25 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 258 | 0.020 |
Why?
|
| Aneuploidy | 1 | 1990 | 152 | 0.020 |
Why?
|
| Pigment Epithelium of Eye | 1 | 1989 | 37 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1990 | 301 | 0.020 |
Why?
|
| Rabbits | 2 | 2000 | 709 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 4335 | 0.020 |
Why?
|
| Serotonin | 1 | 1990 | 229 | 0.020 |
Why?
|
| Ethoxzolamide | 1 | 1988 | 2 | 0.020 |
Why?
|
| Aqueous Humor | 1 | 1988 | 27 | 0.020 |
Why?
|
| Child | 4 | 2023 | 24356 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 208 | 0.020 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 1988 | 24 | 0.020 |
Why?
|
| Thiazoles | 1 | 1988 | 98 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 1990 | 795 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1989 | 173 | 0.020 |
Why?
|
| Conjunctiva | 2 | 1999 | 197 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 8990 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12286 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1990 | 1527 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 565 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2009 | 16273 | 0.010 |
Why?
|
| Prognosis | 1 | 1990 | 4609 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 1162 | 0.010 |
Why?
|
| Virulence | 1 | 2000 | 262 | 0.010 |
Why?
|
| Triamcinolone Acetonide | 1 | 1999 | 37 | 0.010 |
Why?
|
| Animals | 4 | 2003 | 34004 | 0.010 |
Why?
|
| Electrophoresis, Cellulose Acetate | 1 | 1998 | 3 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1998 | 33 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 1998 | 45 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6281 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1998 | 708 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2003 | 13998 | 0.010 |
Why?
|
| Prednisone | 1 | 1996 | 275 | 0.010 |
Why?
|
| Risk Factors | 1 | 2009 | 10244 | 0.010 |
Why?
|
| Body Weight | 1 | 1998 | 996 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 418 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1996 | 280 | 0.010 |
Why?
|
| Skull | 1 | 1994 | 142 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2420 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 1988 | 30 | 0.000 |
Why?
|
| Conjunctivitis | 1 | 1988 | 22 | 0.000 |
Why?
|
| Permeability | 1 | 1988 | 119 | 0.000 |
Why?
|
| Reference Values | 1 | 1988 | 711 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1988 | 272 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 19243 | 0.000 |
Why?
|
| Mice | 1 | 1998 | 17586 | 0.000 |
Why?
|